Cannabinoid Hyperemesis Syndrome, 2016 to 2022

In this cross-sectional study of US ED visits, CHS prevalence increased sharply during the COVID-19 pandemic and remained elevated. The findings highlight the need for continued vigilance and refinements to the clinical recognition of CHS.

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2025-11-24
DOI
https://doi.org/10.1001/jamanetworkopen.2025.45310
Citations
4
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
5.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cannabinoid Hyperemesis Syndrome, 2016 to 2022

Dana Franceschini, James A. Swartz
4 citations
JAMA Network Open
Cannabis and Cannabinoid Research
5.58
article

Cannabinoid Hyperemesis Syndrome, 2016 to 2022

Dana Franceschini, James A. Swartz
article en
4 citations

Abstract

In this cross-sectional study of US ED visits, CHS prevalence increased sharply during the COVID-19 pandemic and remained elevated. The findings highlight the need for continued vigilance and refinements to the clinical recognition of CHS.

JAMA Network OpenVol. 8(11)
University of Illinois Chicago (US)
Illinois Department of Human Services
Openalex Percentile: Top 4%
Cannabis and Cannabinoid Research
5.58
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cannabinoid Hyperemesis Syndrome, 2016 to 2022 — Dana Franceschini, James A. Swartz · JAMA Network Open (2025) | TGRS Research Map | TGRS